Aliskiren Reduces Myocardial Ischemia–Reperfusion Injury by a Bradykinin B 2 Receptor– and Angiotensin AT 2 Receptor–Mediated Mechanism
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Aliskiren Reduces Myocardial Ischemia–Reperfusion Injury by a Bradykinin B
2
Receptor– and Angiotensin AT
2
Receptor–Mediated Mechanism
Authors
Keywords
-
Journal
HYPERTENSION
Volume 63, Issue 4, Pages 768-773
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2014-01-14
DOI
10.1161/hypertensionaha.113.02902
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Direct Renin Inhibition Exerts an Anti-hypertrophic Effect Associated with Improved Mitochondrial Function in Post-infarction Heart Failure in Diabetic Rats
- (2013) Rebecca Parodi-Rullan et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Effect of Aliskiren on Postdischarge Mortality and Heart Failure Readmissions Among Patients Hospitalized for Heart Failure
- (2013) Mihai Gheorghiade et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease: Executive Summary
- (2012) Stephan D. Fihn et al. CIRCULATION
- Angiotensin-converting enzyme 2, angiotensin-(1–7) and Mas: new players of the renin–angiotensin system
- (2012) Robson A S Santos et al. JOURNAL OF ENDOCRINOLOGY
- A Meta-Analysis Reporting Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Patients Without Heart Failure
- (2012) Gianluigi Savarese et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Cardiorenal End Points in a Trial of Aliskiren for Type 2 Diabetes
- (2012) Hans-Henrik Parving et al. NEW ENGLAND JOURNAL OF MEDICINE
- Impact of kinins in the treatment of cardiovascular diseases
- (2012) Domenico Regoli et al. PHARMACOLOGY & THERAPEUTICS
- Aliskiren and Valsartan Reduce Myocardial AT1 Receptor Expression and Limit Myocardial Infarct Size in Diabetic Mice
- (2011) Yumei Ye et al. CARDIOVASCULAR DRUGS AND THERAPY
- Aliskiren increases bradykinin and tissue kallikrein mRNA levels in the heart
- (2011) Duncan J Campbell et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Effect of the direct renin inhibitor aliskiren on left ventricular remodelling following myocardial infarction with systolic dysfunction
- (2011) Scott D. Solomon et al. EUROPEAN HEART JOURNAL
- Aliskiren in combination with valsartan exerts synergistic protective effects against ventricular remodeling after myocardial infarction in mice
- (2011) Yasutomi Higashikuni et al. HYPERTENSION RESEARCH
- Genetically determined angiotensin converting enzyme level and myocardial tolerance to ischemia
- (2010) Erij Messadi et al. FASEB JOURNAL
- Role of Kinin B 2 Receptor Signaling in the Recruitment of Circulating Progenitor Cells With Neovascularization Potential
- (2008) Nicolle Kränkel et al. CIRCULATION RESEARCH
- Renin Inhibitor Aliskiren Improves Impaired Nitric Oxide Bioavailability and Protects Against Atherosclerotic Changes
- (2008) Toshio Imanishi et al. HYPERTENSION
- Renin Inhibition by Aliskiren Prevents Atherosclerosis Progression
- (2008) Jürg Nussberger et al. HYPERTENSION
- Renin Inhibition Improves Cardiac Function and Remodeling After Myocardial Infarction Independent of Blood Pressure
- (2008) Dirk Westermann et al. HYPERTENSION
- Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
- AT2 receptors: Functional relevance in cardiovascular disease
- (2008) Emma S. Jones et al. PHARMACOLOGY & THERAPEUTICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now